Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses.
The study of the pulse using the technique of applanation tonometry is undergoing a resurgence with the development of new computerized equipment. We aim here to present a critical review of the uses, potential uses, strengths and weaknesses of the technique of applanation tonometry for the assessment of augmentation index and pulse wave velocity. We will review the technique of applanation tonometry, the physiological factors affecting pulse wave velocity and pulse wave analysis, the changes in pulse wave velocity and pulse wave analysis with pharmacological interventions, and the use of the technique of applanation tonometry as a prognostic tool. We conclude that, although the technique of applanation tonometry initially seems promising, several pertinent issues need to be addressed before it can be used reliably as a clinical or research tool. Importantly, use of the technique of applanation tonometry to derive the central waveform from non-invasively acquired peripheral data needs to be validated prospectively.
Davies
Justine Ina
JI
Department of Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland, UK. j.i.davies@dundee.ac.uk
Struthers
Allan D
AD
D000375:Aging; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D001795:Blood Pressure Determination / Q000379:methods* / Q000706:statistics & numerical data; D001827:Body Height; D003430:Cross-Sectional Studies; D006339:Heart Rate; D006352:Heart Ventricles / Q000473:pathology; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D008137:Longitudinal Studies; D008365:Manometry / Q000379:methods* / Q000706:statistics & numerical data; D011379:Prognosis; D015203:Reproducibility of Results; D019722:Sphygmomanometers / Q000706:statistics & numerical data
D000959:Antihypertensive Agents; D000975:Antioxidants